Ashley Magovern, MD
Dermatology · Manhattan Beach, CANPI 1770761207
Payments from drug & device makers
Across 301 payments — averaging $110.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$28K
- Merz North America, Inc.$881
- Sanofi$760
- Galderma Laboratories, L.p.$682
- Biofrontera Inc.$603
- Sun Pharmaceutical Industries Inc.$234
- plus $2K from 26 others
What the payments were for
- Consulting fees$24,13072%
- Speaking & faculty fees$3501%
- Travel & lodging$2,5598%
- Food & beverage$6,32919%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 96 | $28,170 |
| Merz North America, Inc. | 8 | $881 |
| Sanofi | 27 | $760 |
| Galderma Laboratories, L.p. | 38 | $682 |
| Biofrontera Inc. | 10 | $603 |
| Sun Pharmaceutical Industries Inc. | 10 | $234 |
| Incyte Corporation | 8 | $207 |
| Johnson & Johnson | 8 | $192 |
| Almirall LLC | 9 | $172 |
| LEO Pharma Inc. | 9 | $167 |
| Regeneron Healthcare Solutions, Inc. | 7 | $162 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $143 |
| Pfizer | 6 | $130 |
| EPI Health, LLC | 6 | $104 |
| Journey Medical Corporation | 6 | $97 |
| Sandoz | 5 | $95 |
| Mayne Pharma Commercial LLC | 15 | $64 |
| UCB, Inc. | 2 | $61 |
| Sebela Pharmaceuticals Inc. | 3 | $56 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $51 |
| VYNE Pharmaceuticals Inc. | 3 | $47 |
| Novartis | 2 | $47 |
| Bristol Myers Squibb | 2 | $44 |
| Aclaris Therapeutics, Inc. | 2 | $32 |
| Prugen, Inc. Pharmaceuticals | 3 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| DUSA Pharmaceuticals, Inc. | 1 | $21 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $21 |
| Revance Therapeutics, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
| Mission Pharmacal Company | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$26,717
- XEOMIN$589
- AMELUZ$350
- BF-RhodoLED$350
- XEPI$350
- BOTOX$125
How this compares
$33,368 in reported general payments places this provider in the 85th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 17 | $1,295 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Manhattan Beach
- Glynis AblonManhattan Beach$1M
- Michelle EhrlichManhattan Beach$735K
- Vivian LaquerIrvine$20.9M
- Howard SofenLos Angeles$16.1M
- Raja SivamaniSacramento$11.8M
- Jennifer SoungSanta Ana$10.3M
- Stacy SmithEncinitas$7.9M
- Paul YamauchiSanta Monica$7.8M
- Navid EzraThousand Oaks$7.8M
- Paul WallaceBeverly Hills$7.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.